Continuous Measurement of the Cumulative Amplitude and Duration of Hyperglycemia Best Predicts Outcome After Traumatic Brain Injury
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
This study aimed to assess the accuracy and utility of high-resolution continuous glucose recording in patients with traumatic brain injury (TBI) and to establish whether a relationship exists between the cumulative amplitude and duration of hyperglycemia and outcome after TBI.
Glucose data for 56 TBI patients were collected continuously at 5-min intervals. The degree and duration of hyperglycemia above treatment thresholds were calculated as “glucose times time dose” (GTD; mg/dL d) using continuous recordings (GTD) for early stage (first 3 days). Long-term neurological functional outcome was assessed using the extended Glasgow Outcome Scale (GOSE). Receiver operating characteristic (ROC) curves were constructed to determine the predictive values of GTD, percentage readings, mean, and range of glucose for in-hospital mortality and GOSE.
All measurements of GTD were statistically significantly higher in the group that died. GTD of glucose >150 and glucose >180 had a high-predictive power for in-hospital mortality (areas under the ROC curve [AUC] = 0.917; 95 % CI, 0.837–0.998 and 0.876; 95 % CI, 0.784–0.967, respectively) and demonstrated significantly higher predictive power for mortality when compared with %reading >150 and %reading >180, respectively (p < 0.05). GTD of glucose >150 also had a significantly higher predictive power for mortality than mean glucose and range of glucose. GTD of glucose >150 and glucose >180 also had a high-predictive power for poor outcome (areas under the ROC curve [AUC] = 0.913; 95 % CI, 0.843–0.983 and 0.858; 95 % CI, 0.760–0.956, respectively).
Continuous collection of glucose recordings is more reliable and accurate than routine discontinuous recordings. Assessing both the duration and the amplitude of the episodes using continuous collection of glucose data helps in better predicting outcomes than the total duration of episodes.
- Hyder AA, Wunderlich CA, Puvanachandra P, et al. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation. 2007;22:341–53.
- Ling GS, Marshall SA. Management of traumatic brain injury in the intensive care unit. Neurol Clin. 2008;26:409–26. CrossRef
- Brain Trauma Foundation. American Association of Neurological Surgeons, Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007;24(suppl 1):S1–106.
- Bullock MR, Chesnut R, Ghajar J, et al. Guidelines for the surgical management of traumatic brain injury. Neurosurgery. 2006;58(2):1–58.
- Bartlett J, Kett-White R, Mendelow AD, et al. Guidelines for the initial management of head injuries. Recommendations from the Society of British Neurological Surgeons. Br J Neurosurg. 1998;12:349–52. CrossRef
- Kreutziger J, Schlaepfer J, Wenzel V, et al. The role of admission blood glucose in outcome prediction of surviving patients with multiple injuries. J Trauma. 2009;67:704–8. CrossRef
- Wahl WL, Taddonio M, Maggio PM, et al. Mean glucose values predict trauma patient mortality. J Trauma. 2008;65:42–8. CrossRef
- Gale SC, Sicoutris C, Reilly PM, et al. Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg. 2007;73:454–60.
- Salim A, Hadjizacharia P, Dubose J, et al. Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg. 2009;75:25–9.
- Mastrototaro JJ. The MiniMed continuous glucose monitoring system. Diabetes Technol Ther. 2000;2(Suppl 1):S13–8. CrossRef
- Goldberg PA, Siegel MD, Russell RR, et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Teehnol Ther. 2004;6:339–47. CrossRef
- Corstjens AM, Ligtenberg JJ, Van der Horst IC, et al. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in criticality ill ICU patients. Crit Care. 2006;10:178. CrossRef
- Piper HG, Alexander JL, Shukh A, et al. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics. 2006;118:1176–84. CrossRef
- De Block C, Manuel-Y-Keenoy B, Van Gaal L, et al. Intensive insulin therapy in the intensive care unit assessment by continuous glucose monitoring. Diabetes Care. 2006;29:1750–6. CrossRef
- Barton CW, Hemphill JC, Morabito D, Manley G. A novel method of evaluating the impact of secondary brain insults on functional outcomes in traumatic brain-injured patients. Acad Emerg Med. 2005;12:1–6. CrossRef
- Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow outcome scale and the extended Glasgow outcome scale: guidelines for their use. J Neurotrauma. 1998;15:573–85. CrossRef
- Souba WW. Nutritional support. N Engl J Med. 1997;336:41–8. CrossRef
- Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67. CrossRef
- Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64:1348–53. CrossRef
- Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomized multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensiv Care Med. 2001;35(10):1738–48. CrossRef
- Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39. CrossRef
- NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97. CrossRef
- Griesdale DE, Tremblay MH, McEwen J, et al. Glucose control and mortality in patients with severe traumatic brain injury. Neurocrit Care. 2009;11:311–6. CrossRef
- Matsushima K, Peng M, Velasco C, et al. Glucose variability negatively impacts long-term functional outcome in patients with traumatic brain injury. J Crit Care. 2011;27(2):125–31. CrossRef
- Allen HF, Rake A, Roy M, et al. Prospective detection of hyperglycemia in critically ill children using continuous glucose monitoring. Pediatr Crit Care Med. 2008;9(2):153–8. CrossRef
- Vik A, Nag T, Fredriksli OA, et al. Relationship of “dose” of intracranial hypertension to outcome in severe traumatic brain injury. J Neurosurg. 2008;109:678–84. CrossRef
- Kahraman S, Dutton RP, Hu P, et al. Automated measurement of “pressure times time dose” of intracranial hypertension best predicts outcome after severe traumatic brain injury. J Trauma. 2010;69:110–8. CrossRef
- Vespa P, Boonyaputthikul R, McArthur DL, et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med. 2006;34:850–6. CrossRef
- Oddo M, Schmidt JM, Carrera E, et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med. 2008;36:3233–8. CrossRef
- Continuous Measurement of the Cumulative Amplitude and Duration of Hyperglycemia Best Predicts Outcome After Traumatic Brain Injury
Volume 20, Issue 1 , pp 69-76
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Traumatic brain injury
- Continuous glucose monitoring system
- Industry Sectors
- Author Affiliations
- 1. Department of Neurosurgery, The Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China
- 2. Department of Neurosurgery, The First People’s Hospital of Kunshan Affiliated to Jiangsu University, Suzhou, China
- 3. Department of Anesthesiology, The Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China
- 4. Department of Neurosurgery, Huashan Hospital Affiliated to Fudan University, Wulumuqizhong Road 12, Shanghai, China